Survey of Ophthalmology
Volume 48, Issue 2, Supplement , Pages S21-S24, April 2003

Retinal Ganglion Cells and Neuroprotection for Glaucoma

  • Leonard A Levin, MD, PhD

      Affiliations

    • Corresponding Author InformationReprint address: Leonard A. Levin, MD, PhD, University of Wisconsin Medical School, 600 Highland Avenue, Madison, WI 53792, USA

Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison, WI, USA

Abstract 

Neuroprotection is a therapeutic strategy directed at keeping retinal ganglion cells (RGCs) alive and functional. This article discusses three commonly asked questions about neuroprotection and attempts to answer them in the context of our current understanding of the pathophysiology of RGC loss in glaucomatous optic neuropathy.

Keywords:  glaucoma, neuroprotection, optic, neuropathy, retinal ganglion cell

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0039-6257(03)00007-9

doi:10.1016/S0039-6257(03)00007-9

Survey of Ophthalmology
Volume 48, Issue 2, Supplement , Pages S21-S24, April 2003

Article Tools

* Image Usage & Resolution